Published in Schizophr Res on November 24, 2012
Schizotypal personality disorder: a current review. Curr Psychiatry Rep (2014) 0.79
Simultaneous effects on parvalbumin-positive interneuron and dopaminergic system development in a transgenic rat model for sporadic schizophrenia. Sci Rep (2016) 0.76
Increased putamen volume in adults with autism spectrum disorder. Front Hum Neurosci (2014) 0.76
Parallel organization of functionally segregated circuits linking basal ganglia and cortex. Annu Rev Neurosci (1986) 18.17
The reward circuit: linking primate anatomy and human imaging. Neuropsychopharmacology (2010) 10.17
Functional anatomy of the basal ganglia. I. The cortico-basal ganglia-thalamo-cortical loop. Brain Res Brain Res Rev (1995) 5.23
The primate basal ganglia: parallel and integrative networks. J Chem Neuroanat (2003) 5.16
MRI anatomy of schizophrenia. Biol Psychiatry (1999) 2.79
Prefrontal dopamine D1 receptors and working memory in schizophrenia. J Neurosci (2002) 2.69
Dopaminergic modulation of synaptic transmission in cortex and striatum. Neuron (2012) 2.46
Brain morphology and schizophrenia. A magnetic resonance imaging study of limbic, prefrontal cortex, and caudate structures. Arch Gen Psychiatry (1992) 2.38
A possible role for the striatum in the pathogenesis of the cognitive symptoms of schizophrenia. Neuron (2010) 1.96
The pathophysiology of schizophrenia disorders: perspectives from the spectrum. Am J Psychiatry (2004) 1.91
MRI study of caudate nucleus volume and its cognitive correlates in neuroleptic-naive patients with schizotypal personality disorder. Am J Psychiatry (2002) 1.72
Increase in caudate nuclei volumes of first-episode schizophrenic patients taking antipsychotic drugs. Am J Psychiatry (1994) 1.72
Shape of caudate nucleus and its cognitive correlates in neuroleptic-naive schizotypal personality disorder. Biol Psychiatry (2004) 1.66
Comparison of hippocampal, amygdala, and perirhinal projections to the nucleus accumbens: combined anterograde and retrograde tracing study in the Macaque brain. J Comp Neurol (2002) 1.46
Changes in caudate volume with neuroleptic treatment. Lancet (1994) 1.43
Schizophrenia as an anomaly of development of cerebral asymmetry. A postmortem study and a proposal concerning the genetic basis of the disease. Arch Gen Psychiatry (1989) 1.38
The amygdalostriatal projections in the monkey. An anterograde tracing study. Brain Res (1985) 1.37
Caudate size in first-episode neuroleptic-naive schizophrenic patients measured using an artificial neural network. Biol Psychiatry (1999) 1.37
Reduction of caudate nucleus volumes in neuroleptic-naïve female subjects with schizotypal personality disorder. Biol Psychiatry (2006) 1.36
Molecular imaging studies of the striatal dopaminergic system in psychosis and predictions for the prodromal phase of psychosis. Br J Psychiatry Suppl (2007) 1.31
Dopamine specifically inhibits forebrain neural stem cell proliferation, suggesting a novel effect of antipsychotic drugs. J Neurosci (2005) 1.29
Neuropsychological performance in schizotypal personality disorder: evidence regarding diagnostic specificity. Biol Psychiatry (2002) 1.27
Caudate, putamen, and globus pallidus volume in schizophrenia: a quantitative MRI study. Psychiatry Res (1995) 1.24
Adjustment for whole brain and cranial size in volumetric brain studies: a review of common adjustment factors and statistical methods. Harv Rev Psychiatry (2006) 1.18
Functional magnetic resonance imaging evidence for disrupted basal ganglia function in schizophrenia. Am J Psychiatry (2001) 1.11
Cognitive and brain function in schizotypal personality disorder. Schizophr Res (2002) 1.10
Striatal metabolic rate and clinical response to neuroleptics in schizophrenia. Arch Gen Psychiatry (1992) 1.08
Cortical gray and white matter volume in unmedicated schizotypal and schizophrenia patients. Schizophr Res (2008) 1.07
Caudate and putamen volumes in good and poor outcome patients with schizophrenia. Schizophr Res (2003) 1.06
The effects of haloperidol on synaptic patterns in the rat striatum. Brain Res (1985) 1.05
Cingulate gyrus volume and metabolism in the schizophrenia spectrum. Schizophr Res (2004) 1.05
Temporal lobe volume determined by magnetic resonance imaging in schizotypal personality disorder and schizophrenia. Schizophr Res (2001) 1.05
Differential metabolic rates in prefrontal and temporal Brodmann areas in schizophrenia and schizotypal personality disorder. Schizophr Res (2002) 1.04
Striatal enlargement in rats chronically treated with neuroleptic. Biol Psychiatry (1998) 1.03
Cerebral asymmetry in schizophrenia. Neuroscientist (2011) 1.02
Dorsal striatal size, shape, and metabolic rate in never-medicated and previously medicated schizophrenics performing a verbal learning task. Arch Gen Psychiatry (1998) 1.02
Defining the caudal ventral striatum in primates: cellular and histochemical features. J Neurosci (2002) 0.99
Basal ganglia volumes in first-episode schizophrenia and healthy comparison subjects. Biol Psychiatry (2002) 0.99
Distribution of GABAergic interneurons and dopaminergic cells in the functional territories of the human striatum. PLoS One (2012) 0.99
An MRI study of superior temporal gyrus volume in women with schizotypal personality disorder. Am J Psychiatry (2003) 0.95
Striatal size and relative glucose metabolic rate in schizotypal personality disorder and schizophrenia. Arch Gen Psychiatry (2001) 0.95
Correlations between MRI-assessed volumes of the thalamus and cortical Brodmann's areas in schizophrenia. Schizophr Res (2004) 0.95
Poor outcome in chronic schizophrenia is associated with progressive loss of volume of the putamen. Schizophr Res (2009) 0.94
Smaller superior temporal gyrus volume specificity in schizotypal personality disorder. Schizophr Res (2009) 0.93
Volume increases in striatum associated with positive symptom reduction in schizophrenia: a preliminary observation. Psychiatry Res (2005) 0.92
Olanzapine increases grey and white matter volumes in the caudate nucleus of patients with schizophrenia. Neuropsychobiology (2007) 0.92
The factor structure of schizotypal symptoms in a clinical population. Schizophr Bull (1996) 0.92
Volume increases in putamen associated with positive symptom reduction in previously drug-naive schizophrenia after 6 weeks antipsychotic treatment. Psychol Med (2011) 0.87
Risperidone and haloperidol promote survival of stem cells in the rat hippocampus. Eur Arch Psychiatry Clin Neurosci (2009) 0.86
Striatal size, glucose metabolic rate, and verbal learning in normal aging. Brain Res Cogn Brain Res (2003) 0.85
A magnetic resonance imaging study in first-episode disorganized-type patients with schizophrenia. Psychiatry Clin Neurosci (1997) 0.84
Effects of acute metabolic stress on the dopaminergic and pituitary-adrenal axis activity in patients with schizotypal personality disorder. Schizophr Res (2004) 0.81
Schizotypy, social cognition, and interpersonal sensitivity. Personal Disord (2012) 0.79
Initial heritability analyses of endophenotypic measures for schizophrenia: the consortium on the genetics of schizophrenia. Arch Gen Psychiatry (2007) 2.91
The borderline diagnosis I: psychopathology, comorbidity, and personality structure. Biol Psychiatry (2002) 2.75
Characterizing affective instability in borderline personality disorder. Am J Psychiatry (2002) 2.44
Scopolamine as an antidepressant: a systematic review. Clin Neuropharmacol (2013) 2.07
Targeting the dopamine D1 receptor in schizophrenia: insights for cognitive dysfunction. Psychopharmacology (Berl) (2004) 2.06
Striatal volume on magnetic resonance imaging and repetitive behaviors in autism. Biol Psychiatry (2005) 1.94
Analysis of 94 candidate genes and 12 endophenotypes for schizophrenia from the Consortium on the Genetics of Schizophrenia. Am J Psychiatry (2011) 1.93
The Consortium on the Genetics of Endophenotypes in Schizophrenia: model recruitment, assessment, and endophenotyping methods for a multisite collaboration. Schizophr Bull (2006) 1.88
The borderline diagnosis II: biology, genetics, and clinical course. Biol Psychiatry (2002) 1.81
Striatal amphetamine-induced dopamine release in patients with schizotypal personality disorder studied with single photon emission computed tomography and [123I]iodobenzamide. Biol Psychiatry (2004) 1.71
Loss and altered spatial distribution of oligodendrocytes in the superior frontal gyrus in schizophrenia. Biol Psychiatry (2003) 1.69
Amygdala-prefrontal disconnection in borderline personality disorder. Neuropsychopharmacology (2007) 1.54
Evidence for a decrease in basilar dendrites of pyramidal cells in schizophrenic medial prefrontal cortex. Schizophr Res (2002) 1.46
Internal capsule, corpus callosum and long associative fibers in good and poor outcome schizophrenia: a diffusion tensor imaging survey. Schizophr Res (2007) 1.44
Abuse and neglect in childhood: relationship to personality disorder diagnoses. CNS Spectr (2003) 1.38
Fronto-limbic dysfunction in response to facial emotion in borderline personality disorder: an event-related fMRI study. Psychiatry Res (2007) 1.36
Relative glucose metabolic rate higher in white matter in patients with schizophrenia. Am J Psychiatry (2007) 1.36
Postmortem assessment of thalamic nuclear volumes in subjects with schizophrenia. Am J Psychiatry (2002) 1.35
Neural correlates of using distancing to regulate emotional responses to social situations. Neuropsychologia (2010) 1.33
Evaluation of behavioral impulsivity and aggression tasks as endophenotypes for borderline personality disorder. J Psychiatr Res (2009) 1.32
Diffusion tensor imaging in schizophrenia. Biol Psychiatry (2006) 1.31
Volumetric analysis and three-dimensional glucose metabolic mapping of the striatum and thalamus in patients with autism spectrum disorders. Am J Psychiatry (2006) 1.31
Genome-wide linkage analyses of 12 endophenotypes for schizophrenia from the Consortium on the Genetics of Schizophrenia. Am J Psychiatry (2013) 1.30
Proposed changes in personality and personality disorder assessment and diagnosis for DSM-5 Part I: Description and rationale. Personal Disord (2011) 1.30
Verbal working memory impairments in individuals with schizophrenia and their first-degree relatives: findings from the Consortium on the Genetics of Schizophrenia. Schizophr Res (2008) 1.29
The interpersonal dimension of borderline personality disorder: toward a neuropeptide model. Am J Psychiatry (2009) 1.28
Personality disorder types proposed for DSM-5. J Pers Disord (2011) 1.27
Neuropsychological performance in schizotypal personality disorder: evidence regarding diagnostic specificity. Biol Psychiatry (2002) 1.27
Successful multi-site measurement of antisaccade performance deficits in schizophrenia. Schizophr Res (2006) 1.25
Reduced anterior and posterior cingulate gray matter in borderline personality disorder. Biol Psychiatry (2005) 1.23
Brain serotonin transporter distribution in subjects with impulsive aggressivity: a positron emission study with [11C]McN 5652. Am J Psychiatry (2005) 1.22
Blunted prefrontal cortical 18fluorodeoxyglucose positron emission tomography response to meta-chlorophenylpiperazine in impulsive aggression. Arch Gen Psychiatry (2002) 1.22
Neural correlates of the use of psychological distancing to regulate responses to negative social cues: a study of patients with borderline personality disorder. Biol Psychiatry (2009) 1.21
Abnormal auditory N100 amplitude: a heritable endophenotype in first-degree relatives of schizophrenia probands. Biol Psychiatry (2008) 1.19
MRI assessment of gray and white matter distribution in Brodmann's areas of the cortex in patients with schizophrenia with good and poor outcomes. Am J Psychiatry (2003) 1.19
Neural correlates of emotion processing in borderline personality disorder. Psychiatry Res (2009) 1.18
The relationship of borderline personality disorder to posttraumatic stress disorder and traumatic events. Am J Psychiatry (2003) 1.17
Laboratory induced aggression: a positron emission tomography study of aggressive individuals with borderline personality disorder. Biol Psychiatry (2009) 1.17
Neuropsychological performance in schizotypal personality disorder: importance of working memory. Am J Psychiatry (2005) 1.17
White matter fractional anisotropy and outcome in schizophrenia. Schizophr Res (2006) 1.15
Differences in DNA methylation between human neuronal and glial cells are concentrated in enhancers and non-CpG sites. Nucleic Acids Res (2013) 1.15
Volume of the cingulate and outcome in schizophrenia. Schizophr Res (2005) 1.13
Diffusion tensor imaging of frontal lobe white matter tracts in schizophrenia. Ann Gen Psychiatry (2006) 1.13
The thalamus and schizophrenia: current status of research. Acta Neuropathol (2008) 1.13
Molecular and genetic evidence for abnormalities in the nodes of Ranvier in schizophrenia. Arch Gen Psychiatry (2011) 1.12
Context-processing deficits in schizotypal personality disorder. J Abnorm Psychol (2004) 1.12
Multi-site studies of acoustic startle and prepulse inhibition in humans: initial experience and methodological considerations based on studies by the Consortium on the Genetics of Schizophrenia. Schizophr Res (2007) 1.11
Exaggerated affect-modulated startle during unpleasant stimuli in borderline personality disorder. Biol Psychiatry (2007) 1.11
Affective lability and affect intensity as core dimensions of bipolar disorders during euthymic period. Psychiatry Res (2008) 1.10
Magnetic resonance imaging of mediodorsal, pulvinar, and centromedian nuclei of the thalamus in patients with schizophrenia. Arch Gen Psychiatry (2003) 1.10
A comprehensive assessment of gray and white matter volumes and their relationship to outcome and severity in schizophrenia. Neuroimage (2007) 1.09
Fluoxetine increases relative metabolic rate in prefrontal cortex in impulsive aggression. Psychopharmacology (Berl) (2004) 1.07
Cortical gray and white matter volume in unmedicated schizotypal and schizophrenia patients. Schizophr Res (2008) 1.07
Context processing in schizotypal personality disorder: evidence of specificity of impairment to the schizophrenia spectrum. J Abnorm Psychol (2008) 1.07
Subcortical oligodendrocyte- and astrocyte-associated gene expression in subjects with schizophrenia, major depression and bipolar disorder. Schizophr Res (2009) 1.06
Potentiated amygdala response to repeated emotional pictures in borderline personality disorder. Biol Psychiatry (2012) 1.06
Frontolimbic structural changes in borderline personality disorder. J Psychiatr Res (2007) 1.05
Cingulate gyrus volume and metabolism in the schizophrenia spectrum. Schizophr Res (2004) 1.05
Deficient attentional modulation of the startle response in patients with schizotypal personality disorder. Am J Psychiatry (2003) 1.04
Differential metabolic rates in prefrontal and temporal Brodmann areas in schizophrenia and schizotypal personality disorder. Schizophr Res (2002) 1.04
Risperidone in the treatment of schizotypal personality disorder. J Clin Psychiatry (2003) 1.03
A system-level transcriptomic analysis of schizophrenia using postmortem brain tissue samples. Arch Gen Psychiatry (2012) 1.02
Ventricular enlargement in schizophrenia related to volume reduction of the thalamus, striatum, and superior temporal cortex. Am J Psychiatry (2004) 1.02
The role of childhood trauma in differences in affective instability in those with personality disorders. CNS Spectr (2003) 1.00
Regional glucose metabolism within cortical Brodmann areas in healthy individuals and autistic patients. Neuropsychobiology (2004) 1.00
24-h Monitoring of plasma norepinephrine, MHPG, cortisol, growth hormone and prolactin in depression. J Psychiatr Res (2004) 1.00
A longitudinal study of the corpus callosum in chronic schizophrenia. Schizophr Res (2009) 0.99
Quieting the affective storm of borderline personality disorder. Am J Psychiatry (2009) 0.99
Inhibition of the P50 cerebral evoked response to repeated auditory stimuli: results from the Consortium on Genetics of Schizophrenia. Schizophr Res (2010) 0.99
Metabolic disconnection between the mediodorsal nucleus of the thalamus and cortical Brodmann's areas of the left hemisphere in schizophrenia. Am J Psychiatry (2005) 0.98
Group and site differences on the California Verbal Learning Test in persons with schizophrenia and their first-degree relatives: findings from the Consortium on the Genetics of Schizophrenia (COGS). Schizophr Res (2011) 0.97
Thalamus size and outcome in schizophrenia. Schizophr Res (2004) 0.97